Since the start of Russia’s 2022 full-scale invasion of Ukraine, transnational drug organizations have been using new drug ...

U.S. needs to pursue evidence-based interventions for substance use disorders. It’s unclear to what degree the Trump ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Eleven percent of Americans with opioid use disorder received opioid substitution therapy, compared to 87% in France and 86% in Norway. In the U.S., overdose deaths occurred at a rate of 324 per 1 ...